2009
DOI: 10.1186/1475-2875-8-179
|View full text |Cite
|
Sign up to set email alerts
|

Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization

Abstract: BackgroundIn an earlier study, it was observed that the vaccination with Plasmodium falciparum enolase can confer partial protection against malaria in mice. Evidence has also build up to indicate that enolases may perform several non-glycolytic functions in pathogens. Investigating the stage-specific expression and sub-cellular localization of a protein may provide insights into its moonlighting functions.MethodsSub-cellular localization of P. falciparum enolase was examined using immunofluorescence assay, im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
61
0
1

Year Published

2012
2012
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(66 citation statements)
references
References 58 publications
4
61
0
1
Order By: Relevance
“…[26][27][28][29][30][31][32][33] Independent studies also have implicated externalized α-enolase and GAPDH on mammalian and pathogen surfaces as sites for plasminogen binding and subsequent activation by host or pathogen activities, [26][27][28]30,31,[34][35][36] and we have demonstrated that externalized glycolytic enzymes on the apoptotic cell surface, including α-enolase, also are sites for plasminogen binding. 12 Although enhanced virulence has been attributed to the presumptive augmentation in mobility through matrix or fibrin clots associated with localized plasminogen activation following binding on the pathogen surface, 37,38 no compelling physiological rationale exists for plasminogen binding on non-invasive bacteria and apoptotic cells.…”
Section: Box 1 the Repertoire Of Innate Apoptotic Immunity Early Transupporting
confidence: 58%
“…[26][27][28][29][30][31][32][33] Independent studies also have implicated externalized α-enolase and GAPDH on mammalian and pathogen surfaces as sites for plasminogen binding and subsequent activation by host or pathogen activities, [26][27][28]30,31,[34][35][36] and we have demonstrated that externalized glycolytic enzymes on the apoptotic cell surface, including α-enolase, also are sites for plasminogen binding. 12 Although enhanced virulence has been attributed to the presumptive augmentation in mobility through matrix or fibrin clots associated with localized plasminogen activation following binding on the pathogen surface, 37,38 no compelling physiological rationale exists for plasminogen binding on non-invasive bacteria and apoptotic cells.…”
Section: Box 1 the Repertoire Of Innate Apoptotic Immunity Early Transupporting
confidence: 58%
“…Surface exposure of glycolytic enzymes has been noted previously in a variety of enteric bacteria and pathogens and is responsible for specific plasminogen binding (17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27). This striking commonality of glycolytic enzyme externalization raises the possibility that the exposure of glycolytic enzymes on microorganisms reflects a subversion of innate apoptotic immunity though apoptotic mimicry that facilitates commensalism or pathogenesis.…”
mentioning
confidence: 74%
“…The diverse localization of P. falciparum enolase suggests that, apart from its catalytic activity, it might play other biological roles. For instance, enolase localized on the merozoite surface may be involved in red blood cell invasion, vacuolar enolase (21). Therefore, it seems that many drugs can induce over-expression of enolase in the parasite.…”
Section: Discussionmentioning
confidence: 99%